Leveraging state-of-the-art computational tools and AI-driven analysis to accelerate the drug development process
Get in TouchUsing 3D structures of biological targets to design molecules with optimal binding properties and therapeutic effects.
Exploring nature's chemistry to discover and optimize bioactive compounds with therapeutic potential.
Predicting how drug candidates interact with target proteins and screening large compound libraries virtually.
Simulating the physical movements of atoms and molecules to understand dynamic biological interactions.
Analyzing complex biological networks to identify novel drug targets and multi-target therapeutic approaches.
Follow our comprehensive pipeline to transform a target into a viable therapeutic candidate:
Virtual screening and binding affinity predictions to identify promising drug candidates.
Atomistic & coarse-grained simulations, free energy calculations, and trajectory analysis.
Multi-target drug discovery and systems biology & pathway analysis for comprehensive therapeutic approaches.
ADMET properties prediction and QSAR analysis for optimal drug candidate selection.
CEO & Chief Scientist
Leading NatGenica Biotech with visionary research and strategic guidance.
Medicinal Chemist
Overseeing Synthetic Drug Development
Engaging in translational research and training the next generation of scientists.
Supporting drug discovery pipelines through integrated computational solutions.
Providing expert insights to accelerate novel therapeutic development.
Contributing to public health initiatives and broader research endeavors.
+91-97892 67042
No.59, Secretariat Colony, Thoraipakkam, Chennai – 600 097, Tamilnadu, India.